Publications by authors named "Frederic Masse"

Claim this Profile
A
Aryl or heteroaryl substituted aminal derivatives of HCV NS5A inhibitor MK-8742.
Wensheng Yu, Craig A Coburn, Anilkumar G Nair, Michael Wong, Stuart B Rosenblum, Frederic Masse

Bioorg Med Chem Lett· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of the Protein Maker as a platform purification system for therapeutic antibody research and development.
Geneviève Hélie, Marie Parat, Frédéric Massé, Cory J Gerdts, Thomas P Loisel

Comput Struct Biotechnol J· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversible cysteine protease inhibitors show promise for a Chagas disease cure.
Momar Ndao, Christian Beaulieu, W Cameron Black, Elise Isabel, Fabio Vasquez-Camargo

Antimicrob Agents Chemother· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trisubstituted ureas as potent and selective mPGES-1 inhibitors.
Jean-François Chiasson, Louise Boulet, Christine Brideau, Anh Chau, David Claveau

Bioorg Med Chem Lett· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Difluoroethylamines as an amide isostere in inhibitors of cathepsin K.
Elise Isabel, Christophe Mellon, Michael J Boyd, Nathalie Chauret, Denis Deschênes

Bioorg Med Chem Lett· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease.
Christian Beaulieu, Elise Isabel, Angélique Fortier, Frédéric Massé, Christophe Mellon

Bioorg Med Chem Lett· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of setileuton, a potent and selective 5-lipoxygenase inhibitor.
Yves Ducharme, Marc Blouin, Christine Brideau, Anne Châteauneuf, Yves Gareau

ACS Med Chem Lett· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of MK-0674, an orally bioavailable cathepsin K inhibitor.
Elise Isabel, Kevin P Bateman, Nathalie Chauret, Wanda Cromlish, Sylvie Desmarais

Bioorg Med Chem Lett· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological activity of a potent and orally bioavailable SCD inhibitor (MF-438).
Serge Léger, W Cameron Black, Denis Deschenes, Sarah Dolman, Jean-Pierre Falgueyret

Bioorg Med Chem Lett· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of disubstituted phenanthrene imidazoles as potent, selective and orally active mPGES-1 inhibitors.
André Giroux, Louise Boulet, Christine Brideau, Anh Chau, David Claveau

Bioorg Med Chem Lett· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological inhibitors to identify roles of cathepsin K in cell-based studies: a comparison of available tools.
Sylvie Desmarais, Frédéric Massé, M David Percival

Biol Chem· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of ketone warheads as alternatives to the nitrile for preparation of potent and selective cathepsin K inhibitors.
Michael J Boyd, Sheldon N Crane, Joël Robichaud, John Scheigetz, W Cameron Black

Bioorg Med Chem Lett· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a nonbasic, nitrile-containing cathepsin K inhibitor (MK-1256) that is efficacious in a monkey model of osteoporosis.
Jöel Robichaud, W Cameron Black, Michel Thérien, Julie Paquet, Renata M Oballa

J Med Chem· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K.
Jacques Yves Gauthier, Nathalie Chauret, Wanda Cromlish, Sylvie Desmarais, Le T Duong

Bioorg Med Chem Lett· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors.
Bernard Côté, Louise Boulet, Christine Brideau, David Claveau, Diane Ethier

Bioorg Med Chem Lett· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The identification of potent, selective, and bioavailable cathepsin S inhibitors.
Jacques Yves Gauthier, W Cameron Black, Isabelle Courchesne, Wanda Cromlish, Sylvie Desmarais

Bioorg Med Chem Lett· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary amides as selective inhibitors of cathepsin K.
Serge Léger, Christopher I Bayly, W Cameron Black, Sylvie Desmarais, Jean-Pierre Falgueyret

Bioorg Med Chem Lett· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta-substituted cyclohexanecarboxamide cathepsin K inhibitors: modification of the 1,2-disubstituted aromatic core.
Joël Robichaud, Christopher I Bayly, W Cameron Black, Sylvie Desmarais, Serge Léger

Bioorg Med Chem Lett· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a potent and selective non-basic cathepsin K inhibitor.
Chun Sing Li, Denis Deschenes, Sylvie Desmarais, Jean-Pierre Falgueyret, Jacques Yves Gauthier

Bioorg Med Chem Lett· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta-substituted cyclohexanecarboxamide: a nonpeptidic framework for the design of potent inhibitors of cathepsin K.
Sheldon N Crane, W Cameron Black, James T Palmer, Dana E Davis, Eduardo Setti

J Med Chem· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity.
Jean-Pierre Falgueyret, Sylvie Desmarais, Renata Oballa, W Cameron Black, Wanda Cromlish

J Med Chem· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K.
W Cameron Black, Christopher I Bayly, Dana E Davis, Sylvie Desmarais, Jean-Pierre Falgueyret

Bioorg Med Chem Lett· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An automated multistep high-throughput screening assay for the identification of lead inhibitors of the inducible enzyme mPGES-1.
Frédéric Massé, Sébastien Guiral, Louis-Jacques Fortin, Elizabeth Cauchon, Diane Ethier

J Biomol Screen· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A role for the malonyl-CoA/long-chain acyl-CoA pathway of lipid signaling in the regulation of insulin secretion in response to both fuel and nonfuel stimuli.
Raphaël Roduit, Christopher Nolan, Cristina Alarcon, Patrick Moore, Annie Barbeau

Diabetes· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis